Pfizer peers

·Pharma & HealthChart ›

Companies like Pfizerlatest year

PfizerPFIZER · FY26 · this company
Market cap—
P/E—
Sales growth—
ROE17.2%
Glaxosmithkline PharmaceuticalsGLAXO · FY26
Open ›
Market cap₹42,319
P/E45.82×
Sales growth+16.6%
ROE49.1%
Abbott IndiaABBOTINDIA · FY26
Open ›
Market cap—
P/E—
Sales growth—
ROE34.5%
Poly MedicurePOLYMED · FY26
Open ›
Market cap₹14,961
P/E46.43×
Sales growth+30.3%
ROE11.0%

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PFIZER₹3,734.40

Pfizer Ltd.

· Pharma & Health
₹ CrorePeersGLAXOABBOTINDIAPOLYMEDONESOURCERAINBOWKIMSJUBLPHARMAVIJAYA
Comp Set
In ₹ Crore except Per Share
Latest Annual
PFIZER
FY26
GLAXO
FY26
ABBOTINDIA
FY26
POLYMED
FY26
Peer
Average
Valuation — at last close
P/E—◆ 45.82×—46.43×46.12×
P/B—18.66×—◆ 4.82×11.74×
EV/EBITDA—◆ 30.21×—32.82×31.52×
Market Cap—₹42,319 Cr—₹14,961 Cr₹28,640 Cr
Growth
Revenue CAGR 3Y1.29%5.53%9.01%◆ 18.91%11.15% -88%
Revenue CAGR 5Y2.39%3.62%9.96%◆ 18.98%10.85% -78%
Net Income CAGR 3Y5.01%19.26%17.80%◆ 21.39%19.48% -74%
Revenue YoY (latest Q)—16.55%—◆ 30.30%23.43%
Net Income YoY (latest Q)—◆ 15.69%—-8.39%3.65%
Profitability
EBITDA Margin◆ 35.88%34.26%27.31%23.59%28.39% +26%
Net Income Margin◆ 28.67%27.11%22.40%17.10%22.20% +29%
Return on Common Equity17.16%◆ 49.11%34.46%10.97%31.51% -46%
Return on Capital Employed19.60%◆ 52.35%38.09%10.60%33.68% -42%
Return on Assets14.69%24.57%◆ 24.99%9.02%19.53% -25%
Credit & Quality
Total Debt/Equity◆ 0.00×0.00×—0.11×0.06× -100%
Interest Coverage89.28×◆ 455.22×72.67×17.87×181.92× -51%
Scale — latest FY
Revenue / Total Income₹2,520 Cr₹3,822 Cr₹6,929 Cr₹1,875 Cr₹4,209 Cr -40%
Net Income₹722 Cr₹1,036 Cr₹1,552 Cr₹321 Cr₹970 Cr -25%
Total Assets₹4,922 Cr₹4,324 Cr₹6,502 Cr₹3,919 Cr₹4,915 Cr 0%
EPS—₹54.52—₹31.79₹43.16
Book Value per Share—₹133.84—₹306.45₹220.14
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.